These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 33308298)

  • 21. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
    Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
    J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis.
    Rui X; Xu Y; Jiang X; Ye W; Huang Y; Jiang J
    Cell Death Dis; 2018 Dec; 9(12):1175. PubMed ID: 30518760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
    Ding Z; Guo L; Deng Z; Li P
    Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA circ‑ACACA regulates proliferation, migration and glycolysis in non‑small‑cell lung carcinoma via miR‑1183 and PI3K/PKB pathway.
    Wu W; Xi W; Li H; Yang M; Yao X
    Int J Mol Med; 2020 Jun; 45(6):1814-1824. PubMed ID: 32236577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA NEAT1 promotes aerobic glycolysis and progression of cervical cancer through WNT/β-catenin/PDK1 axis.
    Su M; Liang Z; Shan S; Gao Y; He L; Liu X; Wang A; Wang H; Cai H
    Cancer Med; 2024 May; 13(9):e7221. PubMed ID: 38733179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
    Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
    Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The knockdown of lncRNA DLGAP1-AS2 suppresses osteosarcoma progression by inhibiting aerobic glycolysis via the miR-451a/HK2 axis.
    Zheng C; Li R; Zheng S; Fang H; Xu M; Zhong L
    Cancer Sci; 2023 Dec; 114(12):4747-4762. PubMed ID: 37817462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis.
    Xu H; Liu Y; Cheng P; Wang C; Liu Y; Zhou W; Xu Y; Ji G
    J Exp Clin Cancer Res; 2020 Dec; 39(1):283. PubMed ID: 33317596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CircCDK17 knockdown inhibits tumor progression and cell glycolysis by downregulaing YWHAZ expression through sponging miR-1294 in cervical cancer.
    Chen R; Liang F; Yan J; Wang Y
    J Ovarian Res; 2022 Feb; 15(1):24. PubMed ID: 35168653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2'-O-methylation via NOP58 recruitment in colorectal cancer.
    Wu H; Qin W; Lu S; Wang X; Zhang J; Sun T; Hu X; Li Y; Chen Q; Wang Y; Zhao H; Piao H; Zhang R; Wei M
    Mol Cancer; 2020 May; 19(1):95. PubMed ID: 32443980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LBX2-AS1/miR-219a-2-3p/FUS/LBX2 positive feedback loop contributes to the proliferation of gastric cancer.
    Yang Z; Dong X; Pu M; Yang H; Chang W; Ji F; Liu T; Wei C; Zhang X; Qiu X
    Gastric Cancer; 2020 May; 23(3):449-463. PubMed ID: 31673844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
    Wang R; Li Y; Du P; Zhang X; Li X; Cheng G
    Life Sci; 2019 Sep; 233():116708. PubMed ID: 31369759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA HAND2-AS1 represses cervical cancer progression by interaction with transcription factor E2F4 at the promoter of C16orf74.
    Gong J; Fan H; Deng J; Zhang Q
    J Cell Mol Med; 2020 Jun; 24(11):6015-6027. PubMed ID: 32314545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
    Feng Z; Chen R; Huang N; Luo C
    Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway.
    Xu F; Huang M; Chen Q; Niu Y; Hu Y; Hu P; Chen D; He C; Huang K; Zeng Z; Tang J; Wang F; Zhao Y; Wang C; Zhao G
    Cancer Res; 2021 Nov; 81(22):5678-5691. PubMed ID: 34593522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
    Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/β-catenin signaling pathway in cervical cancer.
    Hua F; Liu S; Zhu L; Ma N; Jiang S; Yang J
    Biomed Pharmacother; 2017 Aug; 92():1128-1134. PubMed ID: 28628975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H3K27 acetylation-induced lncRNA EIF3J-AS1 improved proliferation and impeded apoptosis of colorectal cancer through miR-3163/YAP1 axis.
    Liu D; Zhang H; Cong J; Cui M; Ma M; Zhang F; Sun H; Chen C
    J Cell Biochem; 2020 Feb; 121(2):1923-1933. PubMed ID: 31709617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit.
    Ma C; Wang X; Yang F; Zang Y; Liu J; Wang X; Xu X; Li W; Jia J; Liu Z
    Mol Cancer; 2020 Nov; 19(1):157. PubMed ID: 33172486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.